Histamine H2 receptor activation exacerbates myocardial ischemia/reperfusion injury by disturbing mitochondrial and endothelial function

Basic Research in Cardiology

Volumn 108, Issue 3, 2013, Pages

  Luo, Tao ^a   Chen, Baihe ^a   Zhao, Zonglei ^a   He, Nvqin ^a   Zeng, Zhi ^a   Wu, Bing ^a   Fukushima, Yasushi ^c   Dai, Meng ^a   Huang, Qiaobing ^a   Xu, Dingli ^a   Bin, Jianping ^a   Kitakaze, Masafumi ^b   Liao, Yulin ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Histamine H2 receptor; Ischemia; Ischemia reperfusion; Mitochondrial permeability; Vascular permeability

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; AMTHAMINE HYDROBROMIDE; CASPASE 3; DEATH ASSOCIATED PROTEIN KINASE; FAMOTIDINE; HISTAMINE; HISTAMINE H2 RECEPTOR; HISTAMINE H2 RECEPTOR AGONIST; MITOGEN ACTIVATED PROTEIN KINASE 1; MOESIN; PROTEIN BAX; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL MEMBRANE PERMEABILITY; CELL VIABILITY; CONTROLLED STUDY; DISEASE EXACERBATION; DOWN REGULATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; ENDOTHELIUM CELL; HEART CELL CULTURE; HEART INFARCTION SIZE; HEART MITOCHONDRION; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HISTAMINE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; ISCHEMIC HEART DISEASE; KNOCKOUT MOUSE; MITOCHONDRIAL PERMEABILITY; MONOLAYER CULTURE; MOUSE; MOUSE STRAIN; NONHUMAN; RAT; RECEPTOR BLOCKING; REPERFUSION INJURY; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR ENDOTHELIUM;

EID: 84874633670     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-013-0342-4     Document Type: Article

References (46)

1. Adyshev DM, Moldobaeva NK, Elangovan VR, Garcia JG, Dudek SM (2011) Differential involvement of ezrin/radixin/moesin proteins in sphingosine 1-phosphate-induced human pulmonary endothelial cell barrier enhancement. Cell Signal 23:2086-2096. doi: 10.1016/j.cellsig.2011.08.003
2. Arroyo-Flores B, Chi-Ahumada E, Briones-Cerecero E, Barajas-Espinosa A, Perez-Aguilar S, de la Rosa AB, Knabb M, Rubio R (2011) Cardiac ischemia and ischemia/reperfusion cause wide proteolysis of the coronary endothelial luminal membrane: possible dysfunctions. Open Cardiovasc Med J 5:239-245. doi: 10.2174/1874192401105010239
3. Asanuma H, Minamino T, Ogai A, Kim J, Asakura M, Komamura K, Sanada S, Fujita M, Hirata A, Wakeno M, Tsukamoto O, Shinozaki Y, Myoishi M, Takashima S, Tomoike H, Kitakaze M (2006) Blockade of histamine H2 receptors protects the heart against ischemia and reperfusion injury in dogs. J Mol Cell Cardiol 40:666-674. doi: 10.1016/j.yjmcc.2006.02.001
4. Bell RM, Kunuthur SP, Hendry C, Bruce-Hickman D, Davidson S, Yellon DM (2013) Matrix metalloproteinase inhibition protects CyPD knockout mice independently of RISK/mPTP signalling: a parallel pathway to protection. Basic Res Cardiol 108:331. doi: 10.1007/s00395-013-0331-7
5. Bot I, de Jager SC, Zernecke A, Lindstedt KA, van Berkel TJ, Weber C, Biessen EA (2007) Perivascular mast cells promote atherogenesis and induce plaque destabilization in apolipoprotein E-deficient mice. Circulation 115:2516-2525. doi: CIRCULATIONAHA.106.660472
6. Clejan S, Japa S, Clemetson C, Hasabnis SS, David O, Talano JV (2002) Blood histamine is associated with coronary artery disease, cardiac events and severity of inflammation and atherosclerosis. J Cell Mol Med 6:583-592. doi: 006.004.09
7. Dandekar RD, Khan MM (2011) Regulation of ERK2 phosphorylation by histamine in splenocytes. Immunopharmacol Immunotoxicol 33:250-258. doi: 10.3109/08923973.2010.499913
8. Di Lisa F, Bernardi P (2006) Mitochondria and ischemia-reperfusion injury of the heart: fixing a hole. Cardiovasc Res 70:191-199. doi: 10.1016/j.cardiores.2006.01.016
9. Di Lisa F, Carpi A, Giorgio V, Bernardi P (2011) The mitochondrial permeability transition pore and cyclophilin D in cardioprotection. Biochim Biophys Acta 1813:1316-1322. doi: 10.1016/j.bbamcr.2011.01.031
10. + T regulatory cell suppressor function via histamine H1 receptor interaction. J Immunol 183:3014-3022. doi: jimmunol.0802509
11. Fukushima Y, Matsui T, Saitoh T, Ichinose M, Tateishi K, Shindo T, Fujishiro M, Sakoda H, Shojima N, Kushiyama A, Fukuda S, Anai M, Ono H, Oka M, Shimizu Y, Kurihara H, Nagai R, Ishikawa T, Asano T, Omata M (2004) Unique roles of G protein-coupled histamine H2 and gastrin receptors in growth and differentiation of gastric mucosa. Eur J Pharmacol 502:243-252. doi: S0014-2999(04)01021-0
12. Galaup A, Gomez E, Souktani R, Durand M, Cazes A, Monnot C, Teillon J, Le Jan S, Bouleti C, Briois G, Philippe J, Pons S, Martin V, Assaly R, Bonnin P, Ratajczak P, Janin A, Thurston G, Valenzuela DM, Murphy AJ, Yancopoulos GD, Tissier R, Berdeaux A, Ghaleh B, Germain S (2012) Protection against myocardial infarction and no-reflow through preservation of vascular integrity by angiopoietin-like 4. Circulation 125:140-149. doi: CIRCULATIONAHA.111.049072
13. Geoffrey R, Jia S, Kwitek AE, Woodliff J, Ghosh S, Lernmark A, Wang X, Hessner MJ (2006) Evidence of a functional role for mast cells in the development of type 1 diabetes mellitus in the BioBreeding rat. J Immunol 177:7275-7286. doi: 177/10/7275
14. Gomez L, Paillard M, Price M, Chen Q, Teixeira G, Spiegel S, Lesnefsky EJ (2011) A novel role for mitochondrial sphingosine-1-phosphate produced by sphingosine kinase-2 in PTP-mediated cell survival during cardioprotection. Basic Res Cardiol 106:1341-1353. doi: 10.1007/s00395-011-0223-7
15. Guo X, Wang L, Chen B, Li Q, Wang J, Zhao M, Wu W, Zhu P, Huang X, Huang Q (2009) ERM protein moesin is phosphorylated by advanced glycation end products and modulates endothelial permeability. Am J Physiol Heart Circ Physiol 297:H238-H246. doi: 10.1152/ajpheart.00196.2009
16. Heusch G, Boengler K, Schulz R (2008) Cardioprotection: nitric oxide, protein kinases, and mitochondria. Circulation 118:1915-1919. doi: 10.1161/CIRCULATIONAHA.108.805242
17. Heusch G, Boengler K, Schulz R (2010) Inhibition of mitochondrial permeability transition pore opening: the Holy Grail of cardioprotection. Basic Res Cardiol 105:151-154. doi: 10.1007/s00395-009-0080-9
18. Heusch G, Kleinbongard P, Skyschally A, Levkau B, Schulz R, Erbel R (2012) The coronary circulation in cardioprotection: more than just one confounder. Cardiovasc Res 94:237-245. doi: 10.1093/cvr/cvr271
19. Kim J, Ogai A, Nakatani S, Hashimura K, Kanzaki H, Komamura K, Asakura M, Asanuma H, Kitamura S, Tomoike H, Kitakaze M (2006) Impact of blockade of histamine H2 receptors on chronic heart failure revealed by retrospective and prospective randomized studies. J Am Coll Cardiol 48:1378-1384. doi: 10.1016/j.jacc.2006.05.069
20. Li J, Umar S, Iorga A, Youn JY, Wang Y, Regitz-Zagrosek V, Cai H, Eghbali M (2012) Cardiac vulnerability to ischemia/reperfusion injury drastically increases in late pregnancy. Basic Res Cardiol 107:271. doi: 10.1007/s00395-012-0271-7
21. Lim SY, Hausenloy DJ, Arjun S, Price AN, Davidson SM, Lythgoe MF, Yellon DM (2011) Mitochondrial cyclophilin-D as a potential therapeutic target for post-myocardial infarction heart failure. J Cell Mol Med 15:2443-2451. doi: 10.1111/j.1582-4934.2010.01235.x
22. Lin MW, Lin AS, Wu DC, Wang SS, Chang FR, Wu YC, Huang YB (2012) Euphol from Euphorbia tirucalli selectively inhibits human gastric cancer cell growth through the induction of ERK1/2-mediated apoptosis. Food Chem Toxicol 50:4333-4339. doi: 10.1016/j.fct.2012.05.029
23. Lin Y, Hupp TR, Stevens C (2010) Death-associated protein kinase (DAPK) and signal transduction: additional roles beyond cell death. FEBS J 277:48-57. doi: 10.1111/j.1742-4658.2009.07411.x
24. Mackins CJ, Kano S, Seyedi N, Schafer U, Reid AC, Machida T, Silver RB, Levi R (2006) Cardiac mast cell-derived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia/reperfusion. J Clin Invest 116:1063-1070. doi: 10.1172/JCI25713
25. Malagelada C, Xifro X, Badiola N, Sabria J, Rodriguez-Alvarez J (2004) Histamine H2-receptor antagonist ranitidine protects against neural death induced by oxygen-glucose deprivation. Stroke 35:2396-2401. doi: 10.1161/01.STR.0000141160.66818.24
26. Masini E, Cuzzocrea S, Bani D, Mazzon E, Muja C, Mastroianni R, Fabrizi F, Pietrangeli P, Marcocci L, Mondovi B, Mannaioni PF, Federico R (2007) Beneficial effects of a plant histaminase in a rat model of splanchnic artery occlusion and reperfusion. Shock 27:409-415. doi: 10.1097/01.shk.0000239763. 97958.84
27. Matsuda N, Jesmin S, Takahashi Y, Hatta E, Kobayashi M, Matsuyama K, Kawakami N, Sakuma I, Gando S, Fukui H, Hattori Y, Levi R (2004) Histamine H1 and H2 receptor gene and protein levels are differentially expressed in the hearts of rodents and humans. J Pharmacol Exp Ther 309:786-795. doi: 10.1124/jpet.103.063065
28. Mebratu Y, Tesfaigzi Y (2009) How ERK1/2 activation controls cell proliferation and cell death: is subcellular localization the answer? Cell Cycle 8:1168-1175. doi: 10.416/cc.8.8.8147
29. Miura T, Tanno M, Sato T (2010) Mitochondrial kinase signalling pathways in myocardial protection from ischaemia/reperfusion-induced necrosis. Cardiovasc Res 88:7-15. doi: 10.1093/cvr/cvq206
30. Neisch AL, Fehon RG (2011) Ezrin, radixin and moesin: key regulators of membrane-cortex interactions and signaling. Curr Opin Cell Biol 23:377-382. doi: 10.1016/j.ceb.2011.04.011
31. Plotnikov A, Zehorai E, Procaccia S, Seger R (2011) The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation. Biochim Biophys Acta 1813:1619-1633. doi: 10.1016/j.bbamcr.2010.12.012
32. Rasola A, Sciacovelli M, Chiara F, Pantic B, Brusilow WS, Bernardi P (2010) Activation of mitochondrial ERK protects cancer cells from death through inhibition of the permeability transition. Proc Natl Acad Sci USA 107:726-731. doi: 10.1073/pnas.0912742107
33. Rozenberg I, Sluka SH, Rohrer L, Hofmann J, Becher B, Akhmedov A, Soliz J, Mocharla P, Boren J, Johansen P, Steffel J, Watanabe T, Luscher TF, Tanner FC (2010) Histamine H1 receptor promotes atherosclerotic lesion formation by increasing vascular permeability for low-density lipoproteins. Arterioscler Thromb Vasc Biol 30:923-930. doi: 10.1161/ATVBAHA.109.201079
34. Stokely ME, Orr EL (2008) Acute effects of calvarial damage on dural mast cells, pial vascular permeability, and cerebral cortical histamine levels in rats and mice. J Neurotrauma 25:52-61. doi: 10.1089/neu.2007.0397
35. Sun C, Wu MH, Guo M, Day ML, Lee ES, Yuan SY (2010) ADAM15 regulates endothelial permeability and neutrophil migration via Src/ERK1/2 signalling. Cardiovasc Res 87:348-355. doi: 10.1093/cvr/cvq060
36. Takahama H, Asanuma H, Sanada S, Fujita M, Sasaki H, Wakeno M, Kim J, Asakura M, Takashima S, Minamino T, Komamura K, Sugimachi M, Kitakaze M (2010) A histamine H(2) receptor blocker ameliorates development of heart failure in dogs independently of beta-adrenergic receptor blockade. Basic Res Cardiol 105:787-794. doi: 10.1007/s00395-010-0119-y
37. Theilmeier G, Schmidt C, Herrmann J, Keul P, Schafers M, Herrgott I, Mersmann J, Larmann J, Hermann S, Stypmann J, Schober O, Hildebrand R, Schulz R, Heusch G, Haude M, von Wnuck Lipinski K, Herzog C, Schmitz M, Erbel R, Chun J, Levkau B (2006) High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor. Circulation 114:1403-1409. doi: 10.1161/CIRCULATIONAHA.105.607135
38. Toblli JE, DiGennaro F, Giani JF, Dominici FP (2012) Nebivolol: impact on cardiac and endothelial function and clinical utility. Vasc Health Risk Manag 8:151-160. doi: 10.2147/VHRM.S20669
39. van der Goot H, Timmerman H (2000) Selective ligands as tools to study histamine receptors. Eur J Med Chem 35:5-20. doi: 10.1016/S0223-5234(00)00101-X
40. Wallukat G (2002) The beta-adrenergic receptors. Herz 27:683-690. doi: 10.1007/s00059-002-2434-z
41. Wang KY, Tanimoto A, Guo X, Yamada S, Shimajiri S, Murata Y, Ding Y, Tsutsui M, Kato S, Watanabe T, Ohtsu H, Hirano K, Kohno K, Sasaguri Y (2011) Histamine deficiency decreases atherosclerosis and inflammatory response in apolipoprotein E knockout mice independently of serum cholesterol level. Arterioscler Thromb Vasc Biol 31:800-807. doi: 10.1161/ATVBAHA.110.215228
42. Wu CC, Yen CC, Lee I, Su CC, Tang FC, Chen KL, Su YC, Chen YW (2012) Involvement of oxidative stress-induced ERK/JNK activation in the Cu(2 +)/pyrrolidine dithiocarbamate complex-triggered mitochondria-regulated apoptosis in pancreatic beta-cells. Toxicol Lett 208:275-285. doi: 10.1016/j.toxlet.2011.10.022
43. Xing J, Birukova AA (2010) ANP attenuates inflammatory signaling and Rho pathway of lung endothelial permeability induced by LPS and TNFalpha. Microvasc Res 79:56-62. doi: 10.1016/j.mvr.2009.11.006
44. Xu JM, Shi GP (2012) Emerging role of mast cells and macrophages in cardiovascular and metabolic diseases. Endocr Rev 33:71-108. doi: 10.1210/er.2011-0013
45. Xuan W, Liao Y, Chen B, Huang Q, Xu D, Liu Y, Bin J, Kitakaze M (2011) Detrimental effect of fractalkine on myocardial ischaemia and heart failure. Cardiovasc Res 92:385-393. doi: 10.1093/cvr/cvr221
46. Yan Y, Liao Y, Yang L, Wu J, Du J, Xuan W, Ji L, Huang Q, Liu Y, Bin J (2011) Late-phase detection of recent myocardial ischaemia using ultrasound molecular imaging targeted to intercellular adhesion molecule-1. Cardiovasc Res 89:175-183. doi: 10.1093/cvr/cvq269